What is Palbociclib used for?
HR-positive, HER2-negative advanced or metastatic breast cancer (with hormone therapy)
A CDK4/6 inhibitor used for some advanced breast cancers. A current prescription is required for a referral enquiry.
In simple terms
Palbociclib is a CDK4/6 inhibitor. It blocks the enzymes that let cancer cells divide, pausing the cell cycle and slowing tumour growth when combined with hormone therapy.
Brand and medicine details
- Active ingredient
- Palbociclib
- Dispensing location
- Confirmed only if an enquiry can proceed.
- Brand references
- Ibrance, Palnat, Paleno
- Strengths shown
- 75 mg, 100 mg, 125 mg
- Dosage form
- Capsule
A catalogue brand reference does not confirm the manufacturer, pack, source or availability for an individual enquiry. Confirm any proposed substitution with the treating oncology team.
How it may be prescribed
Usually 125 mg once daily for 21 days followed by 7 days off, in 28-day cycles, with hormone therapy - exactly as the oncologist prescribes. Blood counts are monitored.
Possible side effects to discuss with the care team
- Low white blood cells (neutropenia) - monitored by blood tests
- Fatigue
- Nausea, mouth sores
- Infection risk
Requires specialist supervision and regular blood-count monitoring. Report fever or signs of infection promptly. Supplied only against a valid specialist prescription.
Common questions about Palbociclib
Is generic Palbociclib genuine medicine?
Yes. Medrack refers only licensed medicine from a controlled supply chain, either the originator brand or a licensed branded generic from an established manufacturer. It is not an unbranded or unverified copy. The exact brand, manufacturer and pack are confirmed at the enquiry stage, and any proposed medicine should be reviewed with the treating oncology team.
Do I need a prescription for Palbociclib?
Yes. Palbociclib is a prescription medicine. You can start an enquiry before you have the prescription in hand, but nothing proceeds until a current prescription issued in the patient's name has been received and checked. You upload it privately as part of the enquiry.
What happens after you enquire
Every enquiry is assessed individually. A listing on this page does not confirm availability, a dispensing pharmacy or a delivery.
-
You send an enquiry
Add the prescribed medicine and upload the current prescription. This records a request for assessment, not an order.
-
We check the prescription
The medicine, prescription, patient details, destination and supporting documentation are reviewed case by case.
-
We prepare a referral and written terms
Any proposal identifies the responsible dispensing party, the dispensing country, the total charges and the cancellation terms.
-
You confirm and pay
Nothing proceeds until you accept the disclosed terms. Payment is requested only after that written summary has been provided.
-
Dispatch and delivery
Dispatch and delivery dates are estimates. Timing can change with availability, documentation, customs or regulatory decisions outside our control.
Full detail is in delivery and fulfilment, order and fulfilment terms and cancellation and refunds.
Before you send an enquiry
These guides explain what to check and what to ask, so the enquiry arrives complete.
- How to read the medicine name on a cancer prescription A practical, non-medical guide for patients and caregivers who need to identify the medicine, strength and information needed for a prescription-led access request.
- What to ask the oncology team about a medicine A patient and caregiver checklist for discussing a prescribed oral cancer medicine with the treating oncology team.
- How to prepare a cancer medicine access request A simple checklist for patients and caregivers preparing a prescription-led medicine information or access request.
